Modulation of immunoglobulin production by invariant Vα19-Jα33 TCR-bearing cells

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Shimamura, Michio ^a,b,c   Huang, Yi Ying ^b   Hidaka, Hiroshi ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b MITSUBISHI KAGAKU INSTITUTE OF LIFE SCIENCES   (Japan)

^c Foundation for Advancement of International Science   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; GAMMA INTERFERON; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; MANNOSYLTRANSFERASE; OVALBUMIN; T LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE TRANSFER; ALLERGY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME REPRESSION; HOMEOSTASIS; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOREGULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOCYTE; VALPHA19 JALPHA33 T LYMPHOCYTE; VALPHA19I T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CHEMISTRY; METABOLISM; TRANSGENIC MOUSE;

CAPRA HIRCUS; MUS; MUS MUSCULUS;

ANIMALS; CELLS, CULTURED; IMMUNOGLOBULINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVALBUMIN; RECEPTORS, ANTIGEN, T-CELL;

EID: 79959223191     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020915     Document Type: Article

References (27)

1. Porcelli S, Yockey CE, Brenner MB, Balk SP, (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- α/β T cells demonstrates preferential use of several Vβ genes and an invariant α chain. J Exp Med 178: 1-16.
2. Tilloy F, Treiner E, Park S -H, Garcia G, Lemonnier F, et al. (1999) An invariant T cell receptor α chain define a novel TAP-independent major histocompatibility complex class Ib-restricted α/β T cell subpopulation in mammals. J Exp Med 189: 1967-1921.
3. Shimamura M, Huang Y-Y, (2002) Presence of a novel subset of NKT cells bearing an invariant Vα19.1-Jα26 TCR α chain. FEBS Lett 516: 97-100.
4. Treiner E, Duban L, Bahram S, Radosavijevic M, Wanner V, et al. (2003) Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature (London) 422: 164-169.
5. Hashimoto K, Hirai M, Kurosawa Y, (1995) A gene outside the human MHC related to classical HLA class I genes. Science 269: 693-695.
6. Martin E, Treiner E, Duban L, Guerri L, Laude H, et al. (2009) Stepwise development of MAIT cells in mouse and human. PLoS Biol 7: 525-536.
7. Okamoto N, Kanie O, Huang Y-Y, Fujii R, Watanabe H, et al. (2005) Synthetic α-mannosyl ceramide as a potent stimulant for an NKT cell repertoire bearing the invariant Vα19-Jα26 TCR α chain. Chem Biol 12: 677-683.
8. Kawachi I, Maldonado J, Strader C, Gillfillan S, (2006) MR1-restricted Vα19i mucosal-associated invariant T cells are innate T cells in the gut lamina propria that provide a rapid and diverse cytokine response. J Immunol 176: 1618-1627.
9. Shimamura M, Huang Y-Y, Migishima R, Yokoyama M, Saitoh T, et al. (2008) Localization of NK1.1+ invariant Vα19 TCR+ cells in the liver with potential to promptly respond to TCR stimulation. Immunol Lett 121: 38-44.
10. Shimamura M, Huang Y -Y, Kobayashi M, Goji H, (2009) Altered production of immunoregulatory cytokines by invariant Vα19 TCR-bearing cells dependent on the duration and intensity of TCR engagement. Int Immunol 21: 179-185.
11. Croxford JL, Miyake S, Huang, Y-Y, Shimamura M, Yamamura T, (2006) Invariant Vα19i T cells regulate autoimmune inflammation. Nat Immunol 7: 987-994.
12. Shimamura M, Huang, Y-Y, Goji H, Endo S, Migishima R, et al. (2011) Regulation of immunological disorders by invariant Vα19-Jα33 TCR-bearing cells Immunobiol 216: 374-378.
13. Smiley ST, Kaplan MN, Grusby MJ, (2001) Immunoglobulin E production in the absence of interleukin 4-secreting CD1-dependent cells. Science 275: 977-979.
14. Mombaerts P, Clarke AR, Rudnicki MA, Iacomini J, Itohara S, et al. (1992) Mutations in T cell receptor genes α and β block thymocyte development at different stages. Nature (London) 360: 225-231.
15. Shimamura M, Ohteki T, Launois P, Garcia A-M, MacDonald HR, (1997) Thymus-independent generation of NK1+ T cells in vitro from fetal liver precursors. J Immunol 158: 3682-3689.
16. Zhang Y, Lamm WJE, Albert RK, Chi EY, Henderson WR Jr, et al. (1997) Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am J Respir Crit Care Med 155: 661-669.
17. Shimamura M, Okamoto N, Huang YY, Yasuoka J, Morita K, et al. (2006) Induction of promotive rather than suppressive immune responses from a novel NKT cell repertoire Vα19 NKT cell with α-mannosyl ceramide analogues consisting of the immunesuppressant ISP-1 as the sphingosin unit. Eur J Med Chem 41: 569-576.
18. Shimamura M, Okamoto N, Huang Y-Y, Yasuoka J, Morita K, et al. (2007) Modulation of Vα19 NKT cell immune responses by α-mannosyl ceramide derivatives consisting of a series of modified sphingosines. Eur J Immunol 37: 1836-1844.
19. Shimamura M, Huang Y-Y, Okamoto N, Watanabe Y, Murakami R, et al. (2007) Glycolipids with non-reducing end α-mannosyl residues that have potentials to activate invariant Vα19 NKT cells. FEBS J 274: 2921-2932.
20. Schnyder-Candrian S, Togbe D, Couillin IMercierI, Brombacher F, et al. (2006) Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 203: 2715-2725.
21. Le Bourhis L, Martin I, Péguillet I, Guihot A, Froux N, et al. (2010) Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 13: 200-210.
22. Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, et al. (2010) Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 8: e1000407.
23. Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, et al. (1998) Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J Exp Med 188: 1831-1839.
24. Bendelac A, Hunziker RD, Lantz O, (1996) Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J Exp Med 184: 1285-1293.
25. Oki S, Chiba A, Yamamura T, Miyake S, (2004) The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NK T cells. J Clin Invest 113: 1631-1640.
26. Cui J, Watanabe N, Kawano T, Yamashita M, Kamata T, et al. (1999) Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J Exp Med 190: 783-791.
27. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, et al. (2003) Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 9: 582-588.